Treatment Persistence and Compliance with Medications for Chronic Obstructive Pulmonary Disease

Canadian Respiratory Journal. 2007;14(1):25-29 DOI 10.1155/2007/161652

 

Journal Homepage

Journal Title: Canadian Respiratory Journal

ISSN: 1198-2241 (Print); 1916-7245 (Online)

Publisher: Hindawi Limited

LCC Subject Category: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system

Country of publisher: United Kingdom

Language of fulltext: English

Full-text formats available: PDF, HTML, ePUB, XML

 

AUTHORS

Joyce A Cramer (Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA)
Carole Bradley-Kennedy (Boehringer Ingelheim (Canada) Ltd, Burlington, Ontario, Canada)
Alissa Scalera (Pfizer Canada Inc, Kirkland, Quebec, Canada)

EDITORIAL INFORMATION

Blind peer review

Editorial Board

Instructions for authors

Time From Submission to Publication: 38 weeks

 

Abstract | Full Text

BACKGROUND AND OBJECTIVE: Inhaled beta-agonist, anticholinergic and glucocorticoid medications are used to treat asthma and chronic obstructive pulmonary disease (COPD). The present study assessed the patterns of persistence with the above mentioned inhaled medications.